ARTICLE | Distillery Therapeutics
Cancer
February 21, 2018 7:11 PM UTC
Cell culture and mouse studies suggest activating or overexpressing NCR2 could help treat melanoma. In a human melanoma cell line, supernatant from NK cells activated by the NCR2 ligand PDGFDD decreas...
BCIQ Company Profiles